Year |
Citation |
Score |
2022 |
Russell B, Spencer-Bowdage S, Rigby J, O'Kelly J, Kelly P, Page M, Raw C, Allchorne P, Harper P, Crew J, Kockelbergh R, Knight A, Van Hemelrijck M, Bryan RT. The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic. Bjui Compass. 3: 324-326. PMID 35945948 DOI: 10.1002/bco2.153 |
0.348 |
|
2020 |
Spencer-Bowdage S, Russell B, Rigby J, O'Kelly J, Kelly P, Page M, Raw C, Allchorne P, Harper P, Crew J, Kockelbergh R, Knight A, Van Hemelrijck M, Bryan RT. The experience of UK bladder cancer patients during the COVID-19 pandemic: A survey-based snapshot. Bju International. PMID 33124729 DOI: 10.1111/bju.15287 |
0.386 |
|
2012 |
Bhatt J, Cowan N, Protheroe A, Crew J. Recent advances in urinary bladder cancer detection. Expert Review of Anticancer Therapy. 12: 929-39. PMID 22845408 DOI: 10.1586/era.12.73 |
0.335 |
|
2012 |
Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder. Cancer. 118: 3920-7. PMID 22614698 DOI: 10.1002/Cncr.26675 |
0.558 |
|
2012 |
Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic. Bju International. 110: 84-94. PMID 22122739 DOI: 10.1111/j.1464-410X.2011.10664.x |
0.572 |
|
2010 |
Cowan NC, Crew JP. Imaging bladder cancer. Current Opinion in Urology. 20: 409-13. PMID 20625298 DOI: 10.1097/MOU.0b013e32833cbcb9 |
0.33 |
|
2010 |
Ayres BE, Crew JP. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer? Bju International. 105: 14-7. PMID 20089093 DOI: 10.1111/j.1464-410X.2009.09152.x |
0.33 |
|
2010 |
Charlesworth PJ, Kilbey N, Taylor M, Leek R, Cranston D, Turner G, Crew J, Harris A, Protheroe A. Automated uro-oncology data collection: the Cancer Research Uro-Oncology Database. Bju International. 105: 1663-6. PMID 19930178 DOI: 10.1111/j.1464-410X.2009.09058.x |
0.414 |
|
2007 |
Rochester MA, Patel N, Turney BW, Davies DR, Roberts IS, Crew J, Protheroe A, Macaulay VM. The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer. Bju International. 100: 1396-401. PMID 17645417 DOI: 10.1111/j.1464-410X.2007.06931.x |
0.485 |
|
2006 |
Turney BW, Willatt JM, Nixon D, Crew JP, Cowan NC. Computed tomography urography for diagnosing bladder cancer. Bju International. 98: 345-8. PMID 16879676 DOI: 10.1111/j.1464-410X.2006.06216.x |
0.341 |
|
Low-probability matches (unlikely to be authored by this person) |
2023 |
Woodcock VK, Chen JL, Purshouse K, Butcher C, Collins L, Haddon C, Verrall G, Elhussein L, Roberts C, Tarlton A, Rei M, Napolitani G, Salio M, Middleton MR, Cerundolo V, ... Crew J, et al. PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer. Bjui Compass. 4: 322-330. PMID 37025470 DOI: 10.1002/bco2.220 |
0.251 |
|
2018 |
Ashton A, Murthy Kusuma VR, Crew J, Mostafid AH. BCG therapy in NMIBC: How much and for how long?. Archivos Espanoles De Urologia. 71: 342-348. PMID 29745923 |
0.217 |
|
2011 |
Rouprêt M, Drouin SJ, Larré S, Neuzillet Y, Botto H, Hitier M, Rigaud J, Crew J, Xylinas E, Salomon L, Cornu JN, Iborra F, Champetier D, Rozet F, Flamand V, et al. Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study. Annals of Surgical Oncology. 18: 3833-8. PMID 21647762 DOI: 10.1245/S10434-011-1824-Y |
0.207 |
|
2019 |
Tapping CR, Crew J, Proteroe A, Boardman P. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy. Acta Radiologica Open. 8: 2058460119846061. PMID 31218079 DOI: 10.1177/2058460119846061 |
0.19 |
|
2018 |
Doyle E, Crew J, Mostafid H, Tuthill M, Cerundolo V, Gerristen W, Protheroe A. Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non-muscle-invasive disease. Bju International. PMID 30548196 DOI: 10.1111/Bju.14643 |
0.156 |
|
2007 |
Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. Bju International. 99: 1363-70. PMID 17428251 DOI: 10.1111/j.1464-410X.2007.06766.x |
0.153 |
|
2008 |
Meyer JP, Crew J. The risks of diathermy in the urological patient with a pacemaker or an automatic internal cardiac defibrillator. Bju International. 101: 528-9. PMID 18257854 DOI: 10.1111/j.1464-410X.2007.07441.x |
0.124 |
|
2004 |
O'Donoghue JP, Crew JP. Adjuvant topical treatment of upper urinary tract urothelial tumours. Bju International. 94: 483-5. PMID 15329096 DOI: 10.1111/j.1464-410X.2004.04987.x |
0.119 |
|
2018 |
Tapping CR, Macdonald A, Hadi M, Mortensen C, Crew J, Protheroe A, Little MW, Boardman P. Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) with Haematuria in the Absence of an Upper Urinary Tract Pathology. Cardiovascular and Interventional Radiology. PMID 29582127 DOI: 10.1007/s00270-018-1941-0 |
0.089 |
|
2020 |
Tapping CR, Little MW, Macdonald A, Mackinnon T, Kearns D, Macpherson R, Crew J, Boardman P. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes. Cardiovascular and Interventional Radiology. PMID 33210152 DOI: 10.1007/s00270-020-02702-3 |
0.082 |
|
2014 |
Tapping CR, Briggs JH, Little MW, Bratby MJ, Phillips-Hughes J, Crew JP, Boardman P. Retrograde transileal conduit stent placement for obstructed uropathy--success of primary and exchange stent placement. Journal of Vascular and Interventional Radiology : Jvir. 25: 1250-6. PMID 24698196 DOI: 10.1016/j.jvir.2014.02.013 |
0.02 |
|
Hide low-probability matches. |